Martin Ventures partners with Jvion to accelerate the development & availability of Jvion’s predictive analytic solution suite
As published in CHIME, February 27, 2015
Jvion announced today that leading healthcare venture firm, Martin Ventures, is collaborating with the Atlanta-based software company through a strategic partnership that will accelerate the adoption of Jvion’s advanced predictive capabilities suite within the provider market. Jvion is a predictive analytics company that identifies and prevents financial and clinical losses within hospitals. Capitalizing on the growing need for predictions that help prevent patient deterioration and suffering, the support of Martin Ventures will drive further market share and expansion of what is already an award-winning, leading predictive solution suite.
Jvion’s predictive suite has received significant market recognition including: Gartner Cool Vendor for Healthcare Providers; the 2014 Intel Innovation Award; top honors from Fierce Health IT in the “Data Analytics” category, and as an overall award of “Best in Show: Fiercest Cost-Saving Solution.” Financial and clinical use cases are in place at more than 200 facilities across the nation. The resulting analytics are helping providers reduce readmissions, stop hospital acquired conditions and infections, reduce waste, and strategically focus population health initiatives.
Martin Ventures is led by CEO, Chairman and Managing Director Charlie Martin, a healthcare veteran who founded hospital chain company Vanguard Health Systems which was recently acquired by Tenet Healthcare for $4.3B. Martin Ventures, with offices in Nashville, TN, Austin, TX and San Francisco, CA, invests in healthcare and technology initiatives that apply integrative approaches to simultaneously improve care, improve health and reduce the cost of health care. Martin Ventures also invests in companies that develop new technologies that allow consumers to engage in ways that are faster, more efficient and less costly.
“The partnership between Martin Ventures and Jvion is a natural fit,” said Charlie Martin, “This approach to personalized medicine fits centrally within Martin Ventures’ key theme of investing in businesses that share our vision of improving the health of individuals and communities through innovative healthcare technologies and services.“
Shantanu Nigam, Jvion’s CEO, said that, “we are excited to work with Martin Ventures. They are a true catalyst within healthcare and the demonstrated leadership of the Martin Ventures’ team will help extend the reach of Jvion’s predictive suite so that we can help more providers prevent illness and save lives.”